ROC-325
ROC-325 is a potent and orally active autophagy inhibitor with a strong anticancer activity. ROC-325 induces the deacidification of lysosomes, accumulation of autophagosomes, and disrupted autophagic flux. ROC-325 also induces renal cell carcinoma apoptosis[1].
Product Specifications
CAS Number
[1859141-26-6]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; Autophagy
Type
Reference compound
Related Pathways
Apoptosis; Autophagy
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ROC-325.html
Purity
99.45
Solubility
DMSO : 4.55 mg/mL (ultrasonic; warming) |H2O : < 0.1 mg/mL
Smiles
O=C1C2=C(SC3=C1C=CC=C3)C(C)=CC=C2NCCN(CCNC4=CC=NC5=CC(Cl)=CC=C45)C
Molecular Formula
C28H27ClN4OS
Molecular Weight
503.06
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RPLP2, NT (Renal carcinoma antigen NY-REN-44, 60S acidic ribosomal protein P2, RPP2, D11S2243E, RPLP2) (MaxLight 750) discontinued
